NL7003000A - - Google Patents

Info

Publication number
NL7003000A
NL7003000A NL7003000A NL7003000A NL7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A NL 7003000 A NL7003000 A NL 7003000A
Authority
NL
Netherlands
Application number
NL7003000A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7003000A publication Critical patent/NL7003000A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795Porphyrin- or corrin-ring-containing peptides
    • C07K14/80Cytochromes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989Microcapsule with solid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
NL7003000A 1969-03-05 1970-03-03 NL7003000A (https=)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1626669 1969-03-05

Publications (1)

Publication Number Publication Date
NL7003000A true NL7003000A (https=) 1970-09-08

Family

ID=11911735

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7003000A NL7003000A (https=) 1969-03-05 1970-03-03

Country Status (7)

Country Link
US (1) US3642978A (https=)
BR (1) BR7017141D0 (https=)
ES (1) ES377132A1 (https=)
FR (1) FR2060317B1 (https=)
GB (1) GB1238811A (https=)
NL (1) NL7003000A (https=)
SE (1) SE370624B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072667A (en) * 1971-12-22 1978-02-07 Hitachi, Ltd. Process for recovering microbial cellular proteins
JPS5816471B2 (ja) * 1977-11-29 1983-03-31 持田製薬株式会社 免疫化学的測定試薬の安定化剤
US4798786A (en) * 1982-05-06 1989-01-17 Stolle Research And Development Corporation Living cells encapsulated in crosslinked protein
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
AU9113991A (en) * 1990-11-19 1992-06-11 Biotechnology Research And Development Corporation Mutant orientable proteins and coated substrates
EP1301786B1 (en) * 2000-07-21 2005-11-30 Evotec AG Method for the detection of apoptosis by determining cytochrome c as apoptosis-specific marker released into an extracellular medium through cellular release mechanisms
WO2006088832A2 (en) * 2005-02-14 2006-08-24 The Children's Hospital Of Philadelphia Methods for the treatment of sepsis and sepsis-associated cardiac dysfunction
CN110507815B (zh) * 2019-09-30 2023-02-14 成都通德药业有限公司 注射用细胞色素c及其制备方法

Also Published As

Publication number Publication date
DE2010191A1 (de) 1970-09-10
BR7017141D0 (pt) 1973-02-13
SE370624B (https=) 1974-10-28
GB1238811A (https=) 1971-07-14
FR2060317A1 (https=) 1971-06-18
FR2060317B1 (https=) 1974-02-22
ES377132A1 (es) 1972-05-16
US3642978A (en) 1972-02-15

Similar Documents

Publication Publication Date Title
AU465452B2 (https=)
AU429630B2 (https=)
AU5461069A (https=)
FR2060317B1 (https=)
AU2355770A (https=)
AU470301B1 (https=)
CS148793B1 (https=)
AU5113869A (https=)
AU470661B1 (https=)
AU410358B2 (https=)
AT308690B (https=)
AU414607B2 (https=)
AU4923469A (https=)
AU5228269A (https=)
AR203167Q (https=)
CS153821B1 (https=)
AU4949169A (https=)
AU5077469A (https=)
AU5079269A (https=)
AU5109569A (https=)
AU5598769A (https=)
AU5133369A (https=)
AU5397469A (https=)
BG20256A1 (https=)
AU4815038A (https=)